VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation

Clinical trial NCT07273760 · COMPLETED

Trial details

NCT number: NCT07273760
Sponsor: AryoGen Pharmed Co.
Status: COMPLETED
Study type: OBSERVATIONAL

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)

Start date: 2023-07-16
Primary completion: 2025-09-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.